All Sauce from Weekly Sauce:

A drug in development as a cancer therapy may also help the body regenerate damaged nerves after spinal injuries, new research suggests. Scientists at the University of Birmingham in the United Kingdom report that they used cell and animal models to show that the drug, dubbed AZD1390, can block the body’s response to DNA damage…  read on >  read on >

Temperatures are skyrocketing across the United States, as the high sky sun bakes everyone who ventures out for some summer fun. Unfortunately, these record high temperatures increase your risk of experiencing heat-related illnesses during your typical summer activities, said Dr. Maria Mejia, associate professor of family and community medicine at Baylor College of Medicine in…  read on >  read on >

FRIDAY, July 15, 2022 (HealthDay Now) — As a teenager, April Summerford suffered from extremely painful periods that made her suspect something was wrong with her body. Summerford didn’t know it, but she had endometriosis — a condition in which tissue similar to that which lines a woman’s uterus grows outside the uterus, causing pelvic…  read on >  read on >

Roughly 25 million children around the world missed critical vaccinations during 2021, as the pandemic continued to disrupt routine medical care, a new report from the World Health Organization and UNICEF shows. “This is a red alert for child health. We are witnessing the largest sustained drop in childhood immunization in a generation. The consequences…  read on >  read on >

People shouldn’t take the drugs colchicine and fluvoxamine to treat mild to moderate COVID-19, the World Health Organization (WHO) is warning. The antidepressant drug fluvoxamine (Luvox) and the gout drug colchicine are commonly used and inexpensive drugs that have received considerable interest as potential COVID-19 treatments. However, there is insufficient evidence that either drug improves…  read on >  read on >